Blog

- Uncategorized

Widely available nasal spray reduces risk of coronavirus infection by two-thirds, clinical study suggests

A research team at Saarland University has demonstrated in a clinical study that a widely used anti-allergy nasal spray containing the active ingredient azelastine can significantly reduce the risk of infection with the SARS-CoV-2 virus. The results of the placebo-controlled trial involving 450 healthy participants have now been published in JAMA Internal Medicine.

Read More »